Stable dCas9-KRAB and Cas9 Expression Cell Lines

Screens fail quietly when the effector line is inconsistent.

Why the Background Decides the Experiment

In a screen, most of the variance comes from the effector line rather than the guides:

  • • Expression level determines knockdown efficiency and toxicity.
  • • Integration number determines whether effector level drifts at high MOI.
  • • Inducibility determines whether essential genes are tractable.
  • • Per-cell consistency determines how noisy the readout is.

A line that was not characterised on these four axes produces screens that either work spectacularly or not at all, with no diagnostic in between.

What We Supply

Line typeEffectorSelectionTypical use
Cas9 constitutiveSpCas9Puromycin or blasticidinKnockout campaigns, pooled knockout screens
dCas9-KRAB constitutivedCas9–KRABPuromycinCRISPRi knockdown, regulatory element work
dCas9-KRAB inducibledCas9–KRAB under Tet-OnDual selectionEssential genes, titration series
dCas9-VP64 / SAMActivatorDual selectionCRISPRa, sufficiency questions

Each line is delivered with the parental background documented, so results are attributable.

The QC Package

CheckMethodWhat it establishes
Effector expressionWestern blot or intracellular flowProtein present at expected size
Expression levelFlow intensity, compared across clonesModerate, consistent level
Integration numberDigital PCRSingle-copy preferred
Functional performanceControl guides against a known targetKnockdown or editing as expected
InducibilityDose–response to inducerFold induction and leakiness
StabilityExpression at passages 5 and 15No silencing drift

The fourth item is the one that distinguishes a validated line from a transduced pool: a control guide with a known, large effect proves the background works before your library is spent on it.

Why Expression Level Matters More Than People Expect

Very high dCas9–KRAB expression produces global repression and growth defects; very low expression produces partial knockdowns that differ between clones. The useful range is narrow, and it is cell-type-specific.

We therefore deliver clones at a moderate, characterised level rather than the highest-expressing clone — and report the level so that a screen's performance can be interpreted against it.

Limits Worth Knowing

  • • Inducible systems leak. Report baseline repression in the uninduced state; small leaks matter for essential genes.
  • • Effector performance is cell-type specific. A line validated in HEK293 may underperform in iPSC-derived cells; pilot in the target background.
  • • Stable Cas9 lines accumulate edits over time. Bank early passages; do not culture indefinitely.

Frequently Asked

Constitutive or inducible?Constitutive for screens and routine knockdown; inducible when the target is essential or when a titration series is needed. Inducible lines are slower to build and should be chosen for a reason.

How many clones do you provide?Two, at a characterized expression level, with the parental background as control.

Can you put the effector into our line?Yes, with a receipt QC first. If the line proves refractory to transduction or selection, we report that rather than delivering a poorly expressing pool.

Need a characterised effector background?

Tell us the cell type, the readout, and whether you need inducibility. We will confirm which line type fits and what pilot data we can share before you order.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Effector performance varies by cell type, promoter, and integration site; the QC package describes what we measure, not a guarantee of knockdown efficiency in every background.

Inducible systems should be characterized for leakiness and induction kinetics in the target cells.

Selected references for further reading

  • • Gilbert LA, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 2013;154:442–451.
  • • Gilbert LA, et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell. 2014;159:647–661.
  • • Konermann S, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517:583–588.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: